Tiopronin API Market Report – Research, Industry Analysis Reports and Market Demands

Global Tiopronin API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Tiopronin API Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Tiopronin API Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Liver Disease Treatment
- 1.4.3 Detoxification Field
- 1.4.4 Ophthalmology Field
- 1.4.5 Dermatology
- 1.4.6 Others
1.5 Global Tiopronin API Market Size & Forecast
- 1.5.1 Global Tiopronin API Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Tiopronin API Sales Quantity (2021-2032)
- 1.5.3 Global Tiopronin API Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Tiopronin API by Manufacturer

3.1 Global Tiopronin API Sales Quantity by Manufacturer (2021-2026)
3.2 Global Tiopronin API Revenue by Manufacturer (2021-2026)
3.3 Global Tiopronin API Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Tiopronin API by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Tiopronin API Manufacturer Market Share in 2025
- 3.4.3 Top 6 Tiopronin API Manufacturer Market Share in 2025
3.5 Tiopronin API Market: Overall Company Footprint Analysis
- 3.5.1 Tiopronin API Market: Region Footprint
- 3.5.2 Tiopronin API Market: Company Product Type Footprint
- 3.5.3 Tiopronin API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Tiopronin API Market Size by Region
- 4.1.1 Global Tiopronin API Sales Quantity by Region (2021-2032)
- 4.1.2 Global Tiopronin API Consumption Value by Region (2021-2032)
- 4.1.3 Global Tiopronin API Average Price by Region (2021-2032)
4.2 North America Tiopronin API Consumption Value (2021-2032)
4.3 Europe Tiopronin API Consumption Value (2021-2032)
4.4 Asia-Pacific Tiopronin API Consumption Value (2021-2032)
4.5 South America Tiopronin API Consumption Value (2021-2032)
4.6 Middle East & Africa Tiopronin API Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Tiopronin API Sales Quantity by Type (2021-2032)
5.2 Global Tiopronin API Consumption Value by Type (2021-2032)
5.3 Global Tiopronin API Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Tiopronin API Sales Quantity by Application (2021-2032)
6.2 Global Tiopronin API Consumption Value by Application (2021-2032)
6.3 Global Tiopronin API Average Price by Application (2021-2032)

7 North America

7.1 North America Tiopronin API Sales Quantity by Type (2021-2032)
7.2 North America Tiopronin API Sales Quantity by Application (2021-2032)
7.3 North America Tiopronin API Market Size by Country
- 7.3.1 North America Tiopronin API Sales Quantity by Country (2021-2032)
- 7.3.2 North America Tiopronin API Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Tiopronin API Sales Quantity by Type (2021-2032)
8.2 Europe Tiopronin API Sales Quantity by Application (2021-2032)
8.3 Europe Tiopronin API Market Size by Country
- 8.3.1 Europe Tiopronin API Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Tiopronin API Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Tiopronin API Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Tiopronin API Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Tiopronin API Market Size by Region
- 9.3.1 Asia-Pacific Tiopronin API Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Tiopronin API Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Tiopronin API Sales Quantity by Type (2021-2032)
10.2 South America Tiopronin API Sales Quantity by Application (2021-2032)
10.3 South America Tiopronin API Market Size by Country
- 10.3.1 South America Tiopronin API Sales Quantity by Country (2021-2032)
- 10.3.2 South America Tiopronin API Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Tiopronin API Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Tiopronin API Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Tiopronin API Market Size by Country
- 11.3.1 Middle East & Africa Tiopronin API Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Tiopronin API Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Tiopronin API Market Drivers
12.2 Tiopronin API Market Restraints
12.3 Tiopronin API Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Tiopronin API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tiopronin API
13.3 Tiopronin API Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Tiopronin API Typical Distributors
14.3 Tiopronin API Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Tiopronin API market size was valued at US$ 240 million in 2025 and is forecast to a readjusted size of US$ 339 million by 2032 with a CAGR of 5.1% during review period.
Tiopronin API is a glycine derivative containing a free thiol group. Its chemical name is N-(2-mercaptopropionyl)glycine, its molecular formula is C₅H₉NO₃S, its molecular weight is 163.19500, and its appearance is a white crystalline powder with a sulfur odor. The substance is easily soluble in water or ethanol, very slightly soluble in chloroform or ether, and easily soluble in dilute alkaline solutions, with a melting point of 95-97°C. Its core pharmacological action is based on the thiol active group. It exerts a detoxification function by chelating with harmful substances, and can protect liver cells and reduce the toxic side effects of radiotherapy and chemotherapy. It is mainly used clinically to improve liver function of liver diseases such as acute and chronic hepatitis, fatty liver, and alcoholic liver. It also has significant therapeutic effects on diseases such as heavy metal poisoning, senile cataracts, and vitreous opacities.
Tiopronin API participates in the liver protection mechanism by providing thiol groups, which can inhibit liver damage caused by chemicals such as carbon tetrachloride and ethionine, and reduce the accumulation of triglycerides in chronic liver damage. The thiol group in its molecule can also reversibly bind to free radicals, remove excess free radicals in the body, and thus reduce the damage to cells caused by oxidative stress. The API is made into oral tablets, enteric-coated tablets, injections and other dosage forms. When used clinically, it is necessary to strictly follow the scope of indications and avoid using it in special groups such as those who are allergic to the product, pregnant women, lactating women, children, and patients with acute severe lead and mercury poisoning.
This report is a detailed and comprehensive analysis for global Tiopronin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tiopronin API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Tiopronin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Tiopronin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Tiopronin API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tiopronin API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tiopronin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Porton Pharma Solutions, Biophore, MSN Group, Shandong Octagon Chemicals, Hubei Merryclin Pharmaceuticals, Hubei Teyer Pharmaceutical, Jiangsu Disainuo Pharmaceutical, Guizhou Shengjitang Pharmaceutical, XI'AN HAIXIN Pharmaceutical, Shandong Yijian Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tiopronin API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Liver Disease Treatment
Detoxification Field
Ophthalmology Field
Dermatology
Others
Major players covered
Porton Pharma Solutions
Biophore
MSN Group
Shandong Octagon Chemicals
Hubei Merryclin Pharmaceuticals
Hubei Teyer Pharmaceutical
Jiangsu Disainuo Pharmaceutical
Guizhou Shengjitang Pharmaceutical
XI'AN HAIXIN Pharmaceutical
Shandong Yijian Pharmaceutical
Henan Lianyi Pharmaceutical
Liaoning Xinghai Pharmaceutica
Sichuan Ren'an Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tiopronin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tiopronin API, with price, sales quantity, revenue, and global market share of Tiopronin API from 2021 to 2026.
Chapter 3, the Tiopronin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tiopronin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tiopronin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tiopronin API.
Chapter 14 and 15, to describe Tiopronin API sales channel, distributors, customers, research findings and conclusion.

Buy now